EDESA BIOTECH, INC. Deferred Tax Assets, Operating Loss Carryforwards
EDESA BIOTECH, INC. (EDSA) had Deferred Tax Assets, Operating Loss Carryforwards of $10.65 million as of 2018-09-30, per its 10-K filed 2018-11-30.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2018-11-30
- 2018-09-30: Deferred Tax Assets, Operating Loss Carryforwards $10.65M.
- 2017-09-30: Deferred Tax Assets, Operating Loss Carryforwards $12.16M.
- 2016-09-30: Deferred Tax Assets, Operating Loss Carryforwards $10.00M.
- 2015-09-30: Deferred Tax Assets, Operating Loss Carryforwards $8.03M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2018-09-30 | $10.65M 10-K · filed 2018-11-30 |
| 2017-09-30 | $12.16M 10-K · filed 2018-11-30 |
| 2016-09-30 | $10.00M 10-K · filed 2017-12-01 |
| 2015-09-30 | $8.03M 10-K · filed 2017-12-01 |
| 2014-09-30 | $6.56M 10-K · filed 2016-12-14 |
| 2014-08-31 | $6.42M 10-K · filed 2016-12-14 |
| 2013-08-31 | $4.43M 10-K · filed 2015-12-14 |
| 2012-08-31 | $3.41M 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |